Bioventus (BVS) Q4 2025 Earnings Call Transcript

Image source: The Motley Fool.

Thursday, March 5, 2026 astatine 8:30 a.m. ET

• Chief Executive Officer — Robert E. Claypoole

• Chief Financial Officer — Mark L. Singleton

Need a punctuation from a Motley Fool analyst? Email [email protected]

Rob volition statesman his remarks with an update connected our business, reappraisal our show against our 2025 priorities, and laic retired our 2026 objectives. Then Mark volition reappraisal the 4th fourth results and sermon our 2026 fiscal guidance. We volition decorativeness the telephone with Q&A. A presumption for today's telephone is disposable connected the Investors conception of our website, investors.bioventus.com.

Before we begin, I would similar to punctual everyone that our remarks contiguous incorporate forward-looking statements that are based connected the existent expectations of absorption and impact inherent risks and uncertainties that could origin existent results to disagree materially from those indicated, including the risks and uncertainties described successful the company's filings with the SEC, including Item 1A, Risk Factors, of the company's Form 10-K for the twelvemonth ended December 31, 2025, arsenic specified factors whitethorn beryllium updated from clip to clip successful the company's different filings made with the SEC. You are cautioned not to spot undue reliance upon immoderate forward-looking statements, which talk lone arsenic of the day made.

Although the institution whitethorn voluntarily bash truthful from clip to time, it undertakes nary committedness to update oregon revise the forward-looking statements, whether arsenic a effect of caller information, aboriginal events, oregon otherwise, but arsenic required by applicable securities laws. This telephone volition besides see notation to definite fiscal measures that are not calculated successful accordance with U.S. Generally Accepted Accounting Principles, oregon GAAP. We mostly notation to these arsenic non-GAAP oregon adjusted fiscal measures. Important disclosures about, and definitions and reconciliations of, those non-GAAP fiscal measures to the astir comparable measures calculated and presented successful accordance with GAAP are disposable successful the net property merchandise connected the Investors conception of our website astatine investors.bioventus.com.

I volition present crook the telephone implicit to Robert E. Claypoole.

Robert E. Claypoole: Thank you, Dave. Good morning, everyone, and acknowledgment for joining our telephone today. Bioventus Inc. delivered different coagulated 4th and concluded a palmy twelvemonth crossed our strategical priorities portion helping patients retrieve truthful they tin unrecorded beingness to the fullest. Over the past 3 years, we person established a beardown way grounds of gathering oregon exceeding our fiscal guidance portion enhancing our portfolio and importantly strengthening our commercial, operational, and fiscal fundamentals crossed our company. In short, we person transformed Bioventus Inc. It is simply a antithetic institution contiguous with a precise beardown foundation, and we are present entering an breathtaking caller signifier and are good positioned to physique a $1 cardinal starring medtech company.